#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ventricular fibrillation Osteomyelitis Cytokine release syndrome Immunodeficiency congenital Myxoid liposarcoma Gastrooesophageal cancer Chemical burn Arterial tortuosity syndrome Head and neck cancer Juvenile idiopathic arthritis Cognitive disorder Cholestatic pruritus Familial hypertriglyceridaemia Follicular lymphoma stage III Plasma cell myeloma recurrent More trials…

    Learn about Rare Diseases

    Ornithine transcarbamoylase deficiency – Trials in Disease Mucopolysaccharidosis III – Trials in Disease Alagille syndrome – Life with Disease Acquired haemophilia Hairy cell leukaemia recurrent – Diagnostics Fragile X syndrome – Basic Information Anaplastic thyroid cancer – Diagnostics Soft tissue sarcoma – Treatment Rhabdomyosarcoma – Treatment Marfan’s syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Op-1250 Tamibarotene Testosterone Domperidone Azd0305 Arginine Mk-0616 Immunoglobulin G Cefixime Trihydrate Ly3454738 Islatravir AAV9-CTNT-COBAG3 POLYSORBATE 80 Human Serum Albumin Ganaxolone Bevacizumab HAFNIUM OXIDE Guselkumab Ads-011 VANDETANIB More therapies…

    Learn about Your Condition

    Brain neoplasm Peptostreptococcus infection Chronic hepatitis B Ovarian cancer stage IV Agitation Non-Hodgkin's lymphoma Compulsive sexual behaviour Skin cancer Relapsing multiple sclerosis Eosinophilic oesophagitis Meningioma Hairy cell leukaemia recurrent Underweight Endometrial cancer metastatic Ocular lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Comparing Chemotherapy Before or After Surgery for Patients with Upper Tract Urothelial Carcinoma Using Gemcitabine

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Gemcitabine
    The Netherlands Norway Spain Sweden

  • Study on Higher Doses of Rifampicin and Pyrazinamide for Shortened Treatment of Mild-to-Moderate Tuberculosis in Patients with Drug-Sensitive Pulmonary TB

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Tuberculosis
    Investigated Drugs:
    • Pyrazinamide
    • Rifampicin
    Sweden

  • Study on the Effectiveness of Pneumococcal Vaccines PCV13 and PPV23 in Adults with Acute Leukemia or Lymphoma Undergoing Chemotherapy

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 10A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 11A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    France

  • A study of fosfomycin trometamol treatment for male urinary tract infections in primary care settings

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Fosfomycin Trometamol
    France

  • Ketamine Infusion Study for Symptom Improvement in Patients with Severe Borderline Personality Disorder

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Borderline personality disorder
    Investigated Drugs:
    • Ketamine Hydrochloride
    France

  • Study on the Safety of Mercaptamine with Standard Therapy for Hospitalized COVID-19 Pneumonia Patients Not Requiring High Oxygen Flows

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Respiratory tract infection
    • Respiratory tract infection viral
    • COVID-19
    Investigated Drugs:
    • Mercaptamine
    Italy
Previous Page
1 … 903 904 905 906 907 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!